In the early stage of MI, both ACE2 and ACE levels are remarkably increased in the heart, whereas in the late stage, ACE2 expression declines and is accompanied by HF, indicating the role of ACE2 against the RAAS [26]. The gene discussed is ACE2; the disease is myocardial infarction.